SAM #36C24226Q0875

IDIQ Contract for Cytopathology and Next Generation Sequencing Testing Services at Northport VA Medical Center

This opportunity is for an Indefinite Delivery Indefinite Quantity (IDIQ) contract to provide advanced diagnostic testing services at the Northport VA Medical Center in New York. - Government Buyer: - Department of Veterans Affairs, Network Contracting Office 2 (NCO 2), Northport VA Medical Center - Products/Services Requested: - Comprehensive cytopathology evaluation services for thyroid nodules - Clinically validated molecular diagnostic testing using Next Generation Sequencing (NGS) for thyroid nodules with indeterminate Fine Needle Aspiration (FNA) cytology - Minimum of 30 tests and maximum of 600 tests over five years - Unique/Notable Requirements: - Testing must be clinically validated and demonstrate clinical utility - Quality management and experienced personnel are required - The contract allows for options to extend services in increments of one to six months, not exceeding six months total - No specific OEMs or vendors are named in the solicitation - The procurement is focused on improving diagnostic accuracy, reducing unnecessary surgeries, and guiding timely intervention for patients at risk

Description

The Department of Veterans Affairs Network Contracting Office (NCO) 2 is seeking to establish an Indefinite Delivery Indefinite Quantity (IDIQ) Contract to provide comprehensive, clinically validated molecular diagnostic testing using NGS to improve the evaluation and management of thyroid nodules with indeterminate FNA cytology, enhancing diagnostic accuracy, reducing unnecessary surgeries, and guiding timely intervention for patients at risk. Additional Links:VA Northport health care

View original listing